AGEPHA Trademark

Trademark Overview


On Tuesday, March 5, 2019, a trademark application was filed for AGEPHA with the United States Patent and Trademark Office. The USPTO has given the AGEPHA trademark a serial number of 88325857. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, March 20, 2026. This trademark is owned by AGEPHA Pharma s.r.o.. The AGEPHA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and veterinary preparations for the treatment of cardiovascular diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceuticals, namely, anti-infectives; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for ophthalmological use; Pharmaceutical preparations for treating c...
agepha

General Information


Serial Number88325857
Word MarkAGEPHA
Filing DateTuesday, March 5, 2019
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, March 20, 2026
Registration Number6070487
Registration DateTuesday, June 2, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 14, 2020

Trademark Statements


Goods and ServicesPharmaceutical and veterinary preparations for the treatment of cardiovascular diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceuticals, namely, anti-infectives; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for ophthalmological use; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating allergies; Pharmaceutical agents for epidermis; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of gout; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations, namely, ophthalmological preparations; Pharmaceutical preparations, namely, preparations for prophylaxes and/or treatment of the cardiovascular system; Dietetic substances adapted for medical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 22, 2019
Primary Code005
First Use Anywhere DateTuesday, January 1, 2019
First Use In Commerce DateTuesday, January 1, 2019

Trademark Owner History


Party NameMURRAY & POOLE ENTERPRISES LTD.
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressGIBRALTAR
GI

Party NameAGEPHA Pharma s.r.o.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressSenec 90301
SK

Party NameAGEPHA Pharma s.r.o.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSenec 90301
SK

Party NameAGEPHA Pharma s.r.o.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSenec 90301
SK

Trademark Events


Event DateEvent Description
Friday, March 8, 2019NEW APPLICATION ENTERED
Friday, March 22, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 14, 2019ASSIGNED TO EXAMINER
Tuesday, May 21, 2019NON-FINAL ACTION WRITTEN
Tuesday, May 21, 2019NON-FINAL ACTION E-MAILED
Tuesday, May 21, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 11, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 11, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 12, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 6, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 9, 2019ASSIGNED TO LIE
Wednesday, December 25, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 14, 2020PUBLISHED FOR OPPOSITION
Tuesday, January 14, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 10, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, April 9, 2020TEAS STATEMENT OF USE RECEIVED
Friday, April 24, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 9, 2020USE AMENDMENT FILED
Friday, April 24, 2020STATEMENT OF USE PROCESSING COMPLETE
Wednesday, April 29, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, April 30, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 2, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, March 8, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, June 2, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, December 19, 2025TEAS SECTION 8 & 15 RECEIVED
Friday, March 20, 2026CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, March 20, 2026REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, March 20, 2026NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED